A Redlitz, A K Tan, D L Eaton, E F Plow
Title and authors | Publication | Year |
---|---|---|
Biochemical characterization of bovine plasma thrombin-activatable fibrinolysis inhibitor (TAFI)
Z Valnickova, M Thaysen-Andersen, P Højrup, T Christensen, KW Sanggaard, T Kristensen, JJ Enghild |
BMC Biochemistry | 2009 |
A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture
N Okumura, T Koh, Y Hasebe, T Seki, T Ariga |
The Journal of biological chemistry | 2009 |
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?
JL Willemse, E Heylen, ME Nesheim, DF Hendriks |
Journal of Thrombosis and Haemostasis | 2009 |
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism
C Erem, O Ucuncu, M Yilmaz, M Kocak, İ Nuhoglu, HO Ersoz |
Endocrine | 2009 |
Blood coagulation and fibrinolysis in patients with Cushing’s syndrome: Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
C Erem, I Nuhoglu, M Yilmaz, M Kocak, A Demirel, O Ucuncu, HO Ersoz |
Journal of Endocrinological Investigation | 2009 |
Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism
C Erem, M Kocak, I Nuhoglu, M Yilmaz, O Ucuncu |
European Journal of Endocrinology | 2009 |